GRI Bio annual operating expenses
2020
2021
2022
2023
2024
2025
GRI Bio Operating Expenses Growth & History (GRI)
GRI Bio's operating expenses was $12.0M for fiscal 2025.
View full GRI Bio company overviewGRI Bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12.0M | $3.7M | +45.44% |
| 2024 | 2024-12-31 | $8.2M | −$3.2M | −27.68% |
| 2023 | 2023-12-31 | $11.4M | $9.1M | +408.58% |
| 2022 | 2022-12-31 | $2.2M | −$7.0M | −75.82% |
| 2021 | 2021-12-31 | $9.3M | $4.4M | +89.42% |
| 2020 | 2020-12-31 | $4.9M | — | — |
GRI Bio quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.6M | −$1.2M | −43.11% |
| Q1 2026 | 2026-03-31 | $2.0M | −$1.0M | −34.35% |
| Q4 2025 | 2025-12-31 | $2.7M | $711,000 | +36.41% |
| Q3 2025 | 2025-09-30 | $3.4M | $1.2M | +57.98% |
| Q2 2025 | 2025-06-30 | $2.9M | $640,000 | +28.36% |
| Q1 2025 | 2025-03-31 | $3.1M | $1.2M | +61.00% |
| Q4 2024 | 2024-12-31 | $2.0M | −$73,000 | −3.60% |
| Q3 2024 | 2024-09-30 | $2.1M | −$309,000 | −12.67% |
| Q2 2024 | 2024-06-30 | $2.3M | −$3.7M | −61.96% |
| Q1 2024 | 2024-03-31 | $1.9M | $907,000 | +91.80% |
| Q4 2023 | 2023-12-31 | $2.0M | — | — |
| Q3 2023 | 2023-09-30 | $2.4M | $2.3M | +1211.29% |
| Q2 2023 | 2023-06-30 | $5.9M | $5.7M | +3039.68% |
| Q1 2023 | 2023-03-31 | $988,000 | −$1.6M | −62.49% |
| Q3 2022 | 2022-09-30 | $186,000 | −$1.1M | −85.16% |
| Q2 2022 | 2022-06-30 | $189,000 | −$2.1M | −91.82% |
| Q1 2022 | 2022-03-31 | $2.6M | $32,000 | +1.23% |
| Q4 2021 | 2021-12-31 | $3.1M | $1.6M | +111.63% |
| Q3 2021 | 2021-09-30 | $1.3M | $220,000 | +21.30% |
| Q2 2021 | 2021-06-30 | $2.3M | $1.2M | +103.52% |
| Q1 2021 | 2021-03-31 | $2.6M | $1.3M | +106.84% |
| Q4 2020 | 2020-12-31 | $1.5M | — | — |
| Q3 2020 | 2020-09-30 | $1.0M | — | — |
| Q2 2020 | 2020-06-30 | $1.1M | — | — |
| Q1 2020 | 2020-03-31 | $1.3M | — | — |
GRI Bio operating expenses trends
Over the last five fiscal years, GRI Bio's operating expenses increased from $4.9M to $12.0M, a change of $7.1M. The latest reported quarter, Q2 2026, shows $1.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GRI Bio source filings ↗